Business Market R...
Follow
Find
3.4K views | +0 today
 
Scooped by rnrmarketresearch
onto Business Market Research Reports
Scoop.it!

B-Cell Chronic Lymphocytic Leukemia and Systemic Mastocytosis Pipeline Review, H2 2012

B-Cell Chronic Lymphocytic Leukemia and Systemic Mastocytosis Pipeline Review, H2 2012 | Business Market Research Reports | Scoop.it

RnR Market Research, ‘Systemic Mastocytosis – Pipeline Review, H2 2012′, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Systemic Mastocytosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Systemic Mastocytosis. Systemic Mastocytosis – Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by RnR Market Research team.

 

Get your report copy of Systemic Mastocytosis – Pipeline Review, H2 2012 @ http://www.rnrmarketresearch.com/systemic-mastocytosis-pipeline-review-h2-2012-market-report.html

 

RnR Market Research, ‘B-Cell Chronic Lymphocytic Leukemia – Pipeline Review, H2 2012′, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for B-Cell Chronic Lymphocytic Leukemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for B-Cell Chronic Lymphocytic Leukemia. B-Cell Chronic Lymphocytic Leukemia – Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources put together by Global Markets Direct’s team.

 

Get your report copy of B-Cell Chronic Lymphocytic Leukemia – Pipeline Review, H2 2012 @ http://www.rnrmarketresearch.com/b-cell-chronic-lymphocytic-leukemia-pipeline-review-h2-2012-market-report.html

 

Scope

 

- A snapshot of the global therapeutic scenario for Systemic Mastocytosis and B-Cell Chronic Lymphocytic Leukemia.
- A review of the Systemic Mastocytosis and B-Cell Chronic Lymphocytic Leukemia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Systemic Mastocytosis pipeline and B-Cell Chronic Lymphocytic Leukemiaon pipeline the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

 

Reasons to buy

 

- Identify and understand important and diverse types of therapeutics under development for Systemic Mastocytosis and B-Cell Chronic Lymphocytic Leukemia.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Systemic Mastocytosis and B-Cell Chronic Lymphocytic Leukemia pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

more...
No comment yet.
Your new post is loading...
Your new post is loading...
Scooped by rnrmarketresearch
Scoop.it!

Global and China Automotive Connector Industry Worth USD13.1 Billion By 2015 | Business

Global and China Automotive Connector Industry Worth USD13.1 Billion By 2015 | Business | Business Market Research Reports | Scoop.it
As the most potential segment in the connector industry, automotive connectors will trigger the market value of USD12.7 billion (up 5.3% from 2013) in 2014, whilst the global connector market is expected to hit USD50.2 billion (representing a slight...
more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Liquid Milk Industry in China 2014-201

Liquid Milk Industry in China 2014-201 | Business Market Research Reports | Scoop.it
China Liquid Milk Industry Report, 2014-2017 is a market research report available at US $2350 for a Single User PDF License from RnR Market Research Reports Library.
rnrmarketresearch's insight:

Driven by China’s economic development, the improvement of people’s living standards, the adjustment of dietary structure and many other positive factors, China’s dairy product output and demand have increased significantly in recent years. In 2004-2013, China’s dairy product output grew at a CAGR of 12.3%. Chinese dairy products are represented by liquid milk, whose output and retail sales reached 23.36 million tons (accounting for 86.6% of China’s dairy product output) and RMB150.3 billion respectively in 2013. It is projected that China’s liquid milk output and retail sales will hit 35.46 million tons and RMB219.9 billion separately in 2017.

 

Chinese liquid milk falls into high-end and ordinary liquid milk. High-end liquid milk includes Mengniu’s Telunsu, Yili’s Satine and Shuhua Milk, Bright Dairy & Food’s UBEST and U+, Sanyuan’s Extreme and special pure milk products. In recent years, China’s demand for high-end liquid milk has been growing faster than ordinary milk apparently. In 2013, Chinese high-end liquid milk triggered retail sales of RMB43.4 billion, rising 25.4% year on year and occupying 28.9% of the total. In 2017, the retail sales of high-end liquid milk will jump to RMB70.6 billion, equivalent to 32.1% of the total.

 

View Complete Report @ http://www.rnrmarketresearch.com/china-liquid-milk-industry-report-2014-2017-market-report.html .

more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Singapore

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Singapore | Business Market Research Reports | Scoop.it

RnRmarketResearch.com adds report “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Singapore” to its store.

 

The industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Singapore”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Singapore. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

 

Singapore’s population grew from 4.8 million in 2008 to 5.4 million in 2013, mainly due to the increase in the life expectancy (DoS, 2014). The value of the pharmaceuticals market increased from $489m in 2008 to $761m in 2013 at a Compound Annual Growth Rate (CAGR) of 9.3%, and this value is expected to increase further from $776m in 2014 to $873m in 2020 at a CAGR of 2.0% (Tarn et al., 2008; DoS, 2014; EDB, 2014c). In 2011, the output of the medical technology sector was SGD4.3 billion ($3.4 billion), which is expected to increase to SGD5 billion ($4 billion) in 2015 (EDB, 2014a).

 

Complete report available @ http://www.rnrmarketresearch.com/countryfocus-healthcare-regulatory-and-reimbursement-landscape-singapore-market-report.html .

 

These positive growth trends can primarily be attributed to -

 

Government initiativesUniversal healthcare coverage

 

Scope

 

The report provides information on the healthcare, regulatory, and reimbursement landscape in Singapore, and includes -

 

Overview of the pharmaceutical market including size, segmentation, and key drivers and barriersProfiles and SWOT analyses of the major players in the pharmaceutical market: Haw Par Corporation, SciGen, Pfizer, Novartis and GlaxoSmithKlineInsightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devicesDetailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditureAn overview of the opportunities for and challenges to growth in the Singaporean healthcare market

 

Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=250761 .

(This is a premium report priced at US$1995 for a single user PDF.)

 

Reasons to buy

 

This report will enhance your decision-making capability by allowing you to -

 

Develop business strategies by understanding the trends shaping and driving Singapore’s healthcare marketDrive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Singapore’s healthcare market in the futureFormulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitorsOrganize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnershipIdentify, understand, and capitalize on the opportunities and challenges in Singapore’s healthcare market

 

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=250761 .

 

About Us:

RnRmarketResearch.com is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through MarketsandMarkets.com. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

 

 

more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Nuclear Reactor Pressure Vessel and Head Industry to 2020

Nuclear Reactor Pressure Vessel and Head Industry to 2020 | Business Market Research Reports | Scoop.it

RnRmarketResearch.com adds report “Nuclear Reactor Pressure Vessel and Head – Global Market Size, Competitive Landscape and Key Country Analysis to 2020” to its store.

 

“Nuclear Reactor Pressure Vessel and Head – Global Market Size, Competitive Landscape and Key Country Analysis to 2020” is the latest report from GlobalData. It covers the global Nuclear Reactor Pressure Vessel (RPV) and Head (RPVH) market and the key drivers and restraints affecting demand. It also provides the regulatory frameworks governing various countries’ nuclear power industries and provides comprehensive information on key market players and their share them based on their market presence. The market size by volume (units) and value ($m) for nuclear RPV and RPVH in various countries across the world has also been estimated.

 

This report compiles data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

 

Complete report available @ http://www.rnrmarketresearch.com/nuclear-reactor-pressure-vessel-and-head-global-market-size-competitive-landscape-and-key-country-analysis-to-2020-market-report.html .

 

Asia-Pacific has the biggest market for RPV, followed by Europe. In the global nuclear power market, China has the most extensive plans for nuclear development. India is estimated to be the second largest market for nuclear RPV, followed by Russia, US, South Korea, Ukraine and UAE.

 

Scope

 

Analysis of the nuclear reactor pressure vessel and head market in key regions: Asia-Pacific, Europe and North AmericaAnalysis of the nuclear reactor pressure vessel and head market in emerging nuclear country: UAENuclear reactor pressure vessel and head market sizes for 2006–2020Competitive landscape, including market share analysis of nuclear reactor pressure vessel and head suppliers for the covered countries.Qualitative information on market drivers and restraints

 

Reasons to Buy

 

The report will enhance your decision-making capabilities by allowing you to:

 

Identify key regions with potential opportunities for growth in the nuclear reactor pressure vessel and head marketGain insights into the key players active in the nuclear reactor pressure vessel and head market in various countriesUnderstand the emerging opportunities for players in the nuclear reactor pressure vessel and head industry

 

Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=250677 .

(This is a premium report priced at US$5000 for a single user PDF.)

 

List of Tables

 

Table 1: Nuclear Reactor Pressure Vessel and Head Market, Global, Usage Level and Life Span (years), 2010

Table 2: Nuclear Reactor Pressure Vessel and Head Market, Global, Installed Capacity (GW) and Annual Power Generation (TWh), 2000–2025

Table 3: Nuclear Reactor Pressure Vessel and Head Market, Global, Regional Market Size (units) 2006–2020

Table 4: Nuclear Reactor Pressure Vessel and Head Market, Global, Market Size (units), 2006–2020

Table 5: Nuclear Reactor Pressure Vessel and Head Market, Global, Regional Market Value ($bn), 2006–2020

Table 6: Nuclear Reactor Pressure Vessel and Head Market, Global, Market Value ($bn), 2006–2020

Table 7: Nuclear Reactor Pressure Vessel and Head Market, Global, Cumulative RPV Market Share by Installed Capacity (%), 2013

Table 8: Nuclear Reactor Pressure Vessel and Head Market, Global, Cumulative RPVH Market Share by Installed Capacity (%), 2013

Table 9: Nuclear Reactor Pressure Vessel and Head Market, North America, Installed Capacity (GW) and Annual Power Generation (TWh), 2000–2025

Table 10: Nuclear Reactor Pressure Vessel and Head Market, North America, Market Size (units), 2006–2020

Table 11: Nuclear Reactor Pressure Vessel and Head Market, North America, Market Size (units), 2006–2020

Table 12: Nuclear Reactor Pressure Vessel and Head Market, North America, Market Value ($bn), 2006–2020

Table 13: Nuclear Reactor Pressure Vessel and Head Market, North America, Market Value ($bn), 2006–2020

Table 14: Nuclear Reactor Pressure Vessel and Head Market, US, Installed Capacity (GW) and Annual Power Generation (TWh), 2000–2025

Table 15: US Nuclear Regulatory Commission, Regulatory Authorities, 2012

Table 16: Nuclear Reactor Pressure Vessel and Head Market, US, Market Size (units), 2006–2020

Table 17: Nuclear Reactor Pressure Vessel and Head Market, US, Market Value ($m), 2006–2020

Table 18: Nuclear Reactor Pressure Vessel and Head Market, US, Market Share by Cumulative Installed Capacity (%), 2013

Table 19: Nuclear Reactor Pressure Vessel and Head Market, US, Market Share by Cumulative Installed Capacity (%), 2013

Table 20: Nuclear Reactor Pressure Vessel and Head Market, Canada, Installed Capacity (GW) and Annual Power Generation (TWh), 2000–2025

Table 21: Nuclear Reactor Pressure Vessel and Head Market, Canada, RPVH Market Size (units), 2006–2013

Table 22: Nuclear Reactor Pressure Vessel and Head Market, Canada, RPVH Market Value ($m), 2006–2013

Table 23: Nuclear Reactor Pressure Vessel and Head Market, Canada, Active Reactors, 2014

Table 24: Nuclear Reactor Pressure Vessel and Head Market, Europe, Installed Capacity (GW) and Annual Power Generation (TWh), 2000–2025

Table 25: Nuclear Reactor Pressure Vessel and Head Market, Europe, Market Value ($bn), 2006–2020

Table 26: Nuclear Reactor Pressure Vessel and Head Market, Europe, Market Size (units), 2006–2020

Table 27: Nuclear Reactor Pressure Vessel and Head Market, Europe, Market Size (units), 2006–2020

Table 28: Nuclear Reactor Pressure Vessel and Head Market, Europe, Market Value ($m), 2006–2020

Table 29: Nuclear Reactor Pressure Vessel and Head Market, Europe, Market Value ($bn), 2006–2020

Table 30: Nuclear Reactor Pressure Vessel and Head Market, Russia, Installed Capacity (GW) and Annual Power Generation (TWh), 2000–2025

Table 31: Nuclear Reactor Pressure Vessel and Head Market, Russia, Market Size (units), 2006–2020

Table 32: Nuclear Reactor Pressure Vessel and Head Market, Russia, Market Value ($m), 2006–2020

Table 33: Nuclear Reactor Pressure Vessel and Head Market, Russia, Market Share by Cumulative Installed Capacity (%), 2013

Table 34: Nuclear Reactor Pressure Vessel and Head Market, Ukraine, Installed Capacity (GW) and Annual Power Generation (TWh), 2000–2025

Table 35: Nuclear Reactor Pressure Vessel and Head Market, Ukraine, Market Size (units), 2006–2020

Table 36: Nuclear Reactor Pressure Vessel and Head Market, Ukraine, Market Value ($m), 2006–2020

Table 37: Nuclear Reactor Pressure Vessel and Head Market, UK, Installed Capacity (GW) and Annual Power Generation (TWh), 2000–2025

Table 38: Nuclear Reactor Pressure Vessel and Head Market, UK, Market Size (units), 2006–2020

Table 39: Nuclear Reactor Pressure Vessel and Head Market, UK, Market Value ($m), 2006–2020

Table 40: Nuclear Reactor Pressure Vessel and Head Market, UK, Market Share by Cumulative Installed Capacity (%), 2013

Table 41: Nuclear Reactor Pressure Vessel and Head Market UK, Currently Operating Nuclear Reactors, 2014

Table 42: Nuclear Reactor Pressure Vessel and Head Market, Asia-Pacific, Installed Capacity (GW) and Annual Power Generation (TWh), 2000–2025

Table 43: Nuclear Reactor Pressure Vessel and Head Market, Asia-Pacific, Market Value ($m), 2006–2020

Table 44: Nuclear Reactor Pressure Vessel and Head Market, Asia-Pacific, Market Size (units), 2006–2020

Table 45: Nuclear Reactor Pressure Vessel and Head Market, Asia-Pacific, Market Size (units), 2006–2020

Table 46: Nuclear Reactor Pressure Vessel and Head Market, Asia-Pacific, Market Value ($bn), 2006–2020

Table 47: Nuclear Reactor Pressure Vessel and Head Market, Asia-Pacific, Market Value ($bn), 2006–2020

Table 48: Nuclear Reactor Pressure Vessel and Head Market, China, Installed Capacity (GW) and Annual Power Generation (TWh), 2000–2025

Table 49: Nuclear Reactor Pressure Vessel and Head Market, China, Market Size (units), 2006–2020

Table 50: Nuclear Reactor Pressure Vessel and Head Market, China, Market Value ($bn), 2006–2020

 

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=250677 .

 

About Us:

RnRmarketResearch.com is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through MarketsandMarkets.com. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

NovaBay Pharmaceuticals, Inc. – Product Pipeline Review – 2014 – RnR Market Research

NovaBay Pharmaceuticals, Inc. – Product Pipeline Review – 2014 – RnR Market Research | Business Market Research Reports | Scoop.it

RnRmarketResearch.com adds report “NovaBay Pharmaceuticals, Inc. – Product Pipeline Review – 2014” to its store.

 

NovaBay Pharmaceuticals, Inc. Product Pipeline Review 2014′, provides an overview of the NovaBay Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

 

This report provides comprehensive information on the current therapeutic developmental pipeline of NovaBay Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

 

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

 

Complete report available @ http://www.rnrmarketresearch.com/novabay-pharmaceuticals-inc-product-pipeline-review-2014-market-report.html .

 

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

 

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

 

Scope

 

The report provides brief overview of NovaBay Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiariesThe report reviews current pipeline of NovaBay Pharmaceuticals, Inc.’s human therapeutic division and enlists all their major and minor projectsThe report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestonesSpecial feature on out-licensed and partnered product portfolioThe report summarizes all the dormant and discontinued pipeline projectsLatest company statementLatest news and deals relating to the NovaBay Pharmaceuticals, Inc.’s pipeline products

 

Reasons to buy

 

Evaluate NovaBay Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipelineAssess the growth potential of NovaBay Pharmaceuticals, Inc. in its therapy areas of focusIdentify new drug targets and therapeutic classes in the NovaBay Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areasExploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gapsDevelop strategic initiatives by understanding the focus areas of NovaBay Pharmaceuticals, Inc. and exploit collaboration and partnership opportunitiesIdentify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantagePlan mergers and acquisitions effectively by identifying the most promising pipeline of NovaBay Pharmaceuticals, Inc.Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeExplore the dormant and discontinued projects of NovaBay Pharmaceuticals, Inc. and identify potential opportunities in those areasAvoid Intellectual Property Rights related issues

 

Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=250230 .

(This is a premium report priced at US$1500 for a single user PDF.)

 

List of Tables

 

NovaBay Pharmaceuticals, Inc., Key Information 4

NovaBay Pharmaceuticals, Inc., Key Facts 4

NovaBay Pharmaceuticals, Inc. - Pipeline by Indication, 2014 7

NovaBay Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014 8

NovaBay Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014 9

NovaBay Pharmaceuticals, Inc. - Phase II, 2014 10

NovaBay Pharmaceuticals, Inc. - Preclinical, 2014 11

NovaBay Pharmaceuticals, Inc. - Discovery, 2014 12

NovaBay Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2014 18

NovaBay Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2014 19

NovaBay Pharmaceuticals, Inc. - Recent Pipeline Updates, 2014 20

NovaBay Pharmaceuticals, Inc. - Dormant Developmental Projects,2014 24

NovaBay Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2014 25

 

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=250230 .

 

About Us:

RnRmarketResearch.com is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through MarketsandMarkets.com. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

 

 

more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Global Nuclear Imaging- PET and SPECT Equipment Market 2020

Global Nuclear Imaging- PET and SPECT Equipment Market 2020 | Business Market Research Reports | Scoop.it

RnRmarketResearch.com adds report “MediPoint: Nuclear Imaging- PET and SPECT Equipment – Global Analysis and Market Forecasts” to its store.

 

This report examines how new technologies can emerge in the face of economic pressures that may affect the demand for nuclear imaging, and how healthcare reforms are impacting nuclear medicine.

 

The advent of hybrid imaging has enabled PET/CT imaging to undergo explosive growth. However, this has been at the cost of an increased demand on struggling healthcare budgets.

 

PET and SPECT imaging are well established techniques within nuclear imaging, and are the main focus of this report

 

PET imaging uses Positron Emitting radioactive tracers with a short half life, to image metabolically active organs

 

PET combined with CT allows precise anatomical imaging of the body, identifying diseased areas depending upon the tracer used

 

PET/CT is most often used for cancer diagnosis

 

PET/MRI is a new technique that was introduced to reduce patient exposure to radiation

 

Complete report available @ http://www.rnrmarketresearch.com/medipoint-nuclear-imaging-pet-and-spect-equipment-global-analysis-and-market-forecasts-market-report.html .

 

PET only systems are now generally considered obsolete, due to the superior imaging quality of PET/CT

 

SPECT imaging uses Gamma Emitting radioactive tracers with a longer half life, to image molecular processes in the body

 

SPECT and SPECT/CT are most often used in cardiology studies

 

The SPECT and SPECT/CT market is a bigger market than the PET, PET/CT and PET/MRI, because the instruments have been in longer use, are cheaper, and have become the common technique for a wide range of indications

 

Physicians believe more and more SPECT procedures will be replaced by PET procedures

 

New developments in hybrid nuclear imaging promise to further increase the utility of hybrid nuclear imaging, while significantly improving patient cost-savings and safety, through reduced need for repeat examinations.

 

This report focuses on the current and future industry trends within the nuclear medicine market, as well as discussing the promising pipeline products, and assessing the competitive landscape.

 

Questions Answered in this Report

 

What is the current and future nuclear imaging market outlook in the developed and emerging markets? What trends are affecting the global market for both SPECT and PET imaging systems?Which are the key, high growth markets that manufacturers should seek to expand into? What are the types of products that are most likely to succeed?How many Nuclear Imaging Procedures are carried out in each of the 10 Major Markets? What does this imply for instrument adoption rates?What are the major unmet needs in nuclear imaging? In which areas can manufacturers help meet that need?What factors most influence a physician or hospital in the purchase of new nuclear imaging equipment? How much can a physician influence purchasing decisions?How will reimbursement changes will affect nuclear imaging. How has the Affordable Care Act affected nuclear imaging? How will it affect it in the future?How well are new paradigms in nuclear imaging perceived? What motivates companies to develop a new nuclear imaging modality; physician demand or legislative requirement?

 

Regions Covered: US, France, Germany, Italy, Spain, UK, Japan, Brazil, China and India

 

Market Model Features

 

Nuclear Imaging is a moderately growing market, with a CAGR of 3.3% for the period to 2020PET/CT, SPECT, SPECT/CT and Scinitgraphy are the major techniques in nuclear imagingUS dominates the world market for nuclear imaging equipmentUS will see lowest growth in nuclear imaging equipment thanks to reimbursement pressuresJapan and China will present the greatest opportunities for growth, with respective market shares increasing by 75% and almost 100% during the forecasted periodBIC nations will experience the highest growth rates in nuclear imaging equipment during the forecast periodNon-PET nuclear imaging procedures in the developed markets (US, 5EU, Japan) likely overall to fall during forecast period, as a result of increasing reimbursement pressures and new technologiesPET imaging procedures in all markets likely to increase during the forecast period, despite reimbursement pressures, due to increased number of indications

 

Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=250491 .

(This is a premium report priced at US$6495 for a single user PDF.)

 

List of Companies

 

DDD-DiagnosticDigiradGE HealthcareGVI Medical DevicesMediso Medical Imaging SystemsNeurologicaNeusoft Medical SystemsNuCare Medical SystemsOncovisionPhilips HealthcareShimadzuSiemens HealthcareSurgicEyeToshiba MedicalBrain BiosciencesCardiArcCMR NaviscanFMI TechnologiesIntramedical ImagingNIPK ElectronPhoto Diagnostic SystemsPositronShanghai United Imaging HealthcareSpectrum DynamicsSynchroPETZecotek Photonics

 

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=250491 .

 

About Us:

RnRmarketResearch.com is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through MarketsandMarkets.com. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

 

 

more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Global Brain Injury – Pipeline Review, H2 2014

Global Brain Injury – Pipeline Review, H2 2014 | Business Market Research Reports | Scoop.it

RnRmarketResearch.com adds report “Brain Injury – Pipeline Review, H2 2014” to its store.

 

Brain Injury Pipeline Review, H2 2014′, provides an overview of the Brain Injury’s therapeutic pipeline.

 

This report provides comprehensive information on the therapeutic development for Brain Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Brain Injury and special features on late-stage and discontinued projects.

 

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

 

Complete report available @ http://www.rnrmarketresearch.com/brain-injury-pipeline-review-h2-2014-market-report.html .

 

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

 

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

 

Scope

 

The report provides a snapshot of the global therapeutic landscape of Brain InjuryThe report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activitiesThe report reviews key players involved in the therapeutics development for Brain Injury and enlists all their major and minor projectsThe report summarizes all the dormant and discontinued pipeline projectsA review of the Brain Injury products under development by companies and universities/research institutes based on information derived from company and industry-specific sourcesPipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stagesA detailed assessment of monotherapy and combination therapy pipeline projectsCoverage of the Brain Injury pipeline on the basis of target, MoA, route of administration and molecule typeLatest news and deals relating related to pipeline products

 

Reasons to buy

 

Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategiesIdentify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantageDevelop strategic initiatives by understanding the focus areas of leading companiesIdentify and understand important and diverse types of therapeutics under development for Brain InjuryPlan mergers and acquisitions effectively by identifying key players of the most promising pipelineDevise corrective measures for pipeline projects by understanding Brain Injury pipeline depth and focus of Indication therapeuticsDevelop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeModify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

 

Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=250216 .

(This is a premium report priced at US$2000 for a single user PDF.)

 

List of Tables

 

Number of Products under Development for Brain Injury, H2 2014 7

Number of Products under Development for Brain Injury - Comparative Analysis, H2 2014 8

Number of Products under Development by Companies, H2 2014 9

Number of Products under Investigation by Universities/Institutes, H2 2014 10

Comparative Analysis by Early Stage Development, H2 2014 11

Products under Development by Companies, H2 2014 12

Products under Investigation by Universities/Institutes, H2 2014 13

Brain Injury - Pipeline by Acorda Therapeutics, Inc., H2 2014 14

Brain Injury - Pipeline by Biogen Idec Inc., H2 2014 15

Brain Injury - Pipeline by Chiesi Farmaceutici SpA, H2 2014 16

Brain Injury - Pipeline by Faron Pharmaceuticals Oy, H2 2014 17

Brain Injury - Pipeline by Virogenomics, Inc., H2 2014 18

Assessment by Monotherapy Products, H2 2014 19

Number of Products by Stage and Target, H2 2014 21

Number of Products by Stage and Mechanism of Action, H2 2014 23

Number of Products by Stage and Route of Administration, H2 2014 24

Number of Products by Stage and Molecule Type, H2 2014 25

Brain Injury Therapeutics - Recent Pipeline Updates, H2 2014 38

Brain Injury - Dormant Projects, H2 2014 40

Brain Injury - Discontinued Products, H2 2014 41

 

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=250216 .

 

About Us:

RnRmarketResearch.com is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through MarketsandMarkets.com. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

 

 

more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Global Periodontitis Therapeutic Pipeline Market Overview H2 2014

Global Periodontitis Therapeutic Pipeline Market Overview H2 2014 | Business Market Research Reports | Scoop.it

RnRmarketResearch.com adds report “Periodontitis – Pipeline Review, H2 2014” to its store.

 

Periodontitis Pipeline Review, H2 2014′, provides an overview of the Periodontitis’s therapeutic pipeline.

 

This report provides comprehensive information on the therapeutic development for Periodontitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Periodontitis and special features on late-stage and discontinued projects.

 

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

 

Complete report available @ http://www.rnrmarketresearch.com/periodontitis-pipeline-review-h2-2014-market-report.html .

 

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

 

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

 

Scope

 

The report provides a snapshot of the global therapeutic landscape of PeriodontitisThe report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activitiesThe report reviews key players involved in the therapeutics development for Periodontitis and enlists all their major and minor projectsThe report summarizes all the dormant and discontinued pipeline projectsA review of the Periodontitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sourcesPipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stagesA detailed assessment of monotherapy and combination therapy pipeline projectsCoverage of the Periodontitis pipeline on the basis of target, MoA, route of administration and molecule typeLatest news and deals relating related to pipeline products

 

Reasons to buy

 

Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategiesIdentify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantageDevelop strategic initiatives by understanding the focus areas of leading companiesIdentify and understand important and diverse types of therapeutics under development for PeriodontitisPlan mergers and acquisitions effectively by identifying key players of the most promising pipelineDevise corrective measures for pipeline projects by understanding Periodontitis pipeline depth and focus of Indication therapeuticsDevelop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeModify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

 

Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=250213 .

(This is a premium report priced at US$2000 for a single user PDF.)

 

List of Tables

 

Number of Products under Development for Periodontitis, H2 2014 7

Number of Products under Development for Periodontitis - Comparative Analysis, H2 2014 8

Number of Products under Development by Companies, H2 2014 9

Number of Products under Investigation by Universities/Institutes, H2 2014 10

Comparative Analysis by Late Stage Development, H2 2014 11

Comparative Analysis by Early Stage Development, H2 2014 12

Products under Development by Companies, H2 2014 13

Products under Investigation by Universities/Institutes, H2 2014 14

Periodontitis - Pipeline by CSL Limited, H2 2014 15

Periodontitis - Pipeline by Ensoltek Co., Ltd., H2 2014 16

Periodontitis - Pipeline by KAEL-GemVax Co., Ltd., H2 2014 17

Periodontitis - Pipeline by Kaken Pharmaceutical Co., Ltd., H2 2014 18

Periodontitis - Pipeline by NeoStem, Inc., H2 2014 19

Assessment by Monotherapy Products, H2 2014 20

Number of Products by Stage and Target, H2 2014 22

Number of Products by Stage and Mechanism of Action, H2 2014 24

Number of Products by Stage and Route of Administration, H2 2014 26

Number of Products by Stage and Molecule Type, H2 2014 28

Periodontitis Therapeutics - Recent Pipeline Updates, H2 2014 42

Periodontitis - Dormant Projects, H2 2014 44

 

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=250213 .

 

About Us:

RnRmarketResearch.com is your single source for all market research needs. Our database includes 450,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. We offer you customization options on reports by & custom reports through MarketsandMarkets.com. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

 

 

more...
No comment yet.
Scooped by rnrmarketresearch
Scoop.it!

Sarcoidosis Therapeutic Pipeline Market Overview H2 2014

Sarcoidosis Therapeutic Pipeline Market Overview H2 2014 | Business Market Research Reports | Scoop.it

RnRmarketResearch.com adds report “Sarcoidosis – Pipeline Review, H2 2014” to its store.

 

Sarcoidosis Pipeline Review, H2 2014′, provides an overview of the Sarcoidosis’s therapeutic pipeline.

 

This report provides comprehensive information on the therapeutic development for Sarcoidosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Sarcoidosis and special features on late-stage and discontinued projects.

 

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

 

Complete report available @ http://www.rnrmarketresearch.com/sarcoidosis-pipeline-review-h2-2014-market-report.html .

 

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

 

Note*: Certain sections in the report may be removed or altered based on the availability